Intervention

Ropinirole Hydrochloride

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions2

Lead sponsors shown2

Clinical trials

3 shown

Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's DiseaseNCT00260793 · 2005-11-01

A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed ConditionsNCT00674310 · 2004-02-01

A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Und Fasted ConditionsNCT00673088 · 2004-02-01

Common conditions

Parkinson's Disease3 Restless Leg Syndrome2

Leading sponsors

Roxane Laboratories2 Agarwal, Pinky, M.D.1

Trial status mix

COMPLETED2

UNKNOWN1

Phase mix

NA2

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.